MAPKAPK2 and inflammatory bowel disease: Taken together, the current study clearly demonstrates that MMI-0100 plays an important protective role in experimental IBD model mice, suggesting that the MMI-0100/MK2 system may provide a new potential target for the treatment of IBD.